Related Experiment Video
Updated: May 30, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis
1Department of Immunobiology and the Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Abstract:
Mammalian target of rapamycin complex 2 (mTORC2) is a key downstream mediator of phosphoinositol-3-kinase (PI3K) dependent growth factor signaling. In lymphocytes, mTORC2 has emerged as an important regulator of cell development, homeostasis and immune responses. However, our current understanding of mTORC2 functions and the molecular mechanisms regulating mTORC2 signaling in B and T cells are still largely incomplete. Recent studies have begun to shed light on this important pathway. We have previously reported that mTORC2 mediates growth factor dependent phosphorylation of Akt and facilitates Akt dependent phosphorylation and inactivation of transcription factors FoxO1 and FoxO3a. We have recently explored the functions of mTORC2 in B cells and show that mTORC2 plays a key role in regulating survival and immunoglobulin (Ig) gene recombination of bone marrow B cells through an Akt2-FoxO1 dependent mechanism. Ig recombination is suppressed in proliferating B cells to ensure that DNA double strand breaks are not generated in actively dividing cells. Our results raise the possibility that genetic or pharmacologic inhibition of mTORC2 may promote B cell tumor development as a result of inefficient suppression of Ig recombination in dividing B cells. We also propose a novel strategy to treat cancers based on our recent discovery that mTORC2 regulates Akt protein stability.
Insights
Mammalian target of rapamycin complex 2 (mTORC2) regulates B cell survival and immunoglobulin gene recombination. mTORC2 inhibition may increase cancer risk by impairing this process in dividing B cells.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Mammalian target of rapamycin complex 2 (mTORC2) is a critical mediator of phosphoinositol-3-kinase (PI3K) signaling pathways.
- mTORC2 plays a significant role in lymphocyte development, homeostasis, and immune responses.
- The precise functions and regulatory mechanisms of mTORC2 in B and T cells require further elucidation.
Purpose of the Study:
- To investigate the role of mTORC2 in B cell function, specifically survival and immunoglobulin (Ig) gene recombination.
- To explore the molecular mechanisms underlying mTORC2's regulation of these processes in B cells.
- To assess the implications of mTORC2 signaling for B cell-related pathologies and cancer development.
Main Methods:
- Utilized genetic and pharmacologic approaches to modulate mTORC2 activity.
- Analyzed B cell survival and immunoglobulin gene recombination in bone marrow B cells.
- Investigated the involvement of Akt2 and FoxO1 in mTORC2-mediated signaling pathways.
- Examined the effect of mTORC2 on Akt protein stability.
Main Results:
- mTORC2 is crucial for regulating the survival of bone marrow B cells.
- mTORC2 controls immunoglobulin gene recombination in B cells via an Akt2-FoxO1 dependent pathway.
- Ig recombination is suppressed in proliferating B cells to prevent DNA damage.
- mTORC2 regulates Akt protein stability, suggesting a novel therapeutic target.
Conclusions:
- mTORC2 signaling is essential for maintaining B cell homeostasis and preventing aberrant immunoglobulin gene recombination.
- Inhibition of mTORC2 may lead to increased B cell tumor development due to impaired suppression of Ig recombination in dividing cells.
- Targeting mTORC2's regulation of Akt protein stability presents a potential new strategy for cancer treatment.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Mitogens and the Cell Cycle